Pharming (PHAR) Gross Profit Growth (3y) (2023 - 2026)
Pharming (PHAR) Gross Profit Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 54.36% |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 7.16% |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | 3.86% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | 79.18% |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 51.16% |
| 10 | Pharming | 8.96 Bn | 8.91 Bn | 65.80 Mn | 19.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.60% |
| Dec 31, 2025 | -99.15% |
| Sep 30, 2025 | 20.23% |
| Jun 30, 2025 | -98.50% |
| Mar 31, 2025 | -98.81% |
| Dec 31, 2024 | -98.71% |
| Sep 30, 2024 | -98.87% |
| Jun 30, 2024 | 36.00% |
| Mar 31, 2024 | -98.93% |
| Dec 31, 2023 | 11,788.06% |
| Sep 30, 2023 | 6.57% |